Stocks surged on Friday, with the S&P 500 soaring 2.13% as investors welcomed a break from tariff-driven turmoil. The market ...

Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...

As Guillain-Barre Syndrome (GBS) cases rise, so does the social media buzz. Many theories are being floated on the dos and ...

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that ...

The 38 confirmed by Nimhans tested positive for antiganglioside antibodies, which indicates there was a strike on the patients' nervous systems, which eventually led to GBS or related neurological ...

Barre Syndrome (GBS) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This comprehensive analysis of the Guillain-Barré Syndrome (GBS) pipeline is a testament to ...

GBS often starts with mild tingling or weakness ... and Plasma Exchange (Plasmapheresis), which removes harmful antibodies from the blood. Supportive care, such as physical therapy, pain ...

Amid a concerning rise in GBS cases in India, leading experts convened in an ETHealthworld webinar to discuss its possible triggers, challenges in identifying its transmission pathway, and the need ...

The Guillain-Barre Syndrome (GBS) outbreak in Pune has subsided considerably, health officials said on Wednesday, adding that ...

Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting ...

The Guillain-Barre Syndrome is a rare neurological disorder that can cause muscle weakness and paralysis, often triggered by ...